Androstenedione response to recombinant human FSH is the most valid predictor of the number of selected follicles in polycystic ovarian syndrome: (a case-control study)
Abstract Background We aimed to test the hypothesis that the correlation of the changes in the blood Androstenedione (A4) levels to the number of selected follicles during ovulation induction with low-dose recombinant human follicle stimulating hormone (rhFSH) is as strong as the correlation to chan...
Saved in:
Main Authors: | Eser Sefik Ozyurek (Author), Tevfik Yoldemir (Author), Gokhan Artar (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2017-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Calcium alginate microencapsulation of ovarian follicles impacts FSH delivery and follicle morphology
by: McGee Elizabeth A, et al.
Published: (2005) -
Androstenedione as a potential predictor of ovarian response in assisted reproductive technology programs
by: Anna G. Burduli, et al.
Published: (2020) -
Recombinant FSH versus hMG in Controlled Ovarian Stimulation for IVF
by: Agus Supriyadi, et al.
Published: (2021) -
FSH prevents depletion of the resting follicle pool by promoting follicular number and morphology in fresh and cryopreserved primate ovarian tissues following xenografting
by: von Schönfeldt Viktoria, et al.
Published: (2012) -
Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis
by: Grassi Giuseppina, et al.
Published: (2006)